Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Crocs Inc (NASDAQ: CROX) was $119.33 for the day, down -1.12% from the previous closing price of $120.68. In other words, the price has decreased by -$1.12 from its previous closing price. On the day, 0.99 million shares were traded. CROX stock price reached its highest trading level at $122.905 during the session, while it also had its lowest trading level at $118.64.
Ratios:
Our analysis of CROX’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 48.36 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.86. For the most recent quarter (mrq), Quick Ratio is recorded 0.75 and its Current Ratio is at 1.30. In the meantime, Its Debt-to-Equity ratio is 1.37 whereas as Long-Term Debt/Eq ratio is at 1.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on April 01, 2024, initiated with a Overweight rating and assigned the stock a target price of $167.
On February 07, 2024, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $130.
On December 12, 2023, BofA Securities started tracking the stock assigning a Buy rating and target price of $128.BofA Securities initiated its Buy rating on December 12, 2023, with a $128 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 14 ’24 when REPLOGLE JOHN B bought 1,972 shares for $126.75 per share. The transaction valued at 249,949 led to the insider holds 3,153 shares of the business.
Poole Michelle sold 5,074 shares of CROX for $634,144 on Mar 12 ’24. The President now owns 52,966 shares after completing the transaction at $124.98 per share. On Feb 23 ’24, another insider, Hart Daniel P, who serves as the Executive Vice President of the company, sold 10,000 shares for $118.48 each. As a result, the insider received 1,184,823 and left with 219,293 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CROX now has a Market Capitalization of 7219286016 and an Enterprise Value of 9066361856. As of this moment, Crocs’s Price-to-Earnings (P/E) ratio for their current fiscal year is 9.31, and their Forward P/E ratio for the next fiscal year is 8.78. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.82 while its Price-to-Book (P/B) ratio in mrq is 4.97. Its current Enterprise Value per Revenue stands at 2.288 whereas that against EBITDA is 8.242.
Stock Price History:
Over the past 52 weeks, CROX has reached a high of $151.32, while it has fallen to a 52-week low of $74.00. The 50-Day Moving Average of the stock is -4.36%, while the 200-Day Moving Average is calculated to be 13.99%.
Shares Statistics:
CROX traded an average of 1.27M shares per day over the past three months and 1096820 shares per day over the past ten days. A total of 60.49M shares are outstanding, with a floating share count of 58.26M. Insiders hold about 3.71% of the company’s shares, while institutions hold 95.09% stake in the company. Shares short for CROX as of 1711584000 were 5081505 with a Short Ratio of 4.00, compared to 1709164800 on 4526411. Therefore, it implies a Short% of Shares Outstanding of 5081505 and a Short% of Float of 11.6000004.
Earnings Estimates
The current market rating for Crocs Inc (CROX) reflects the collective analysis of Crocs, Inc. analysts closely monitoring its performance.The consensus estimate for the next quarter is $2.42, with high estimates of $15.92 and low estimates of $44.01.
Analysts are recommending an EPS of between $Basic Materials and $Healthcare for the fiscal current year, implying an average EPS of $Healthcare.
